abstract |
The present invention relates to an immunogenic composition comprising an HCMV gB antigen, HCMV pentameric complex antigen gH / gL / UL128 / UL130 / UL131 and Th1 inducing adjuvant. The invention further relates to the immunogenic composition for use as an HCMV vaccine. |